학술논문
Interim Results of a Time and Motion Survey Regarding Subcutaneous Versus Intravenous Administration of Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma
Document Type
Abstract
Author
Source
In Blood 5 November 2020 136 Supplement 1:30-31
Subject
Language
ISSN
0006-4971